Unité de Fabrication des Médicaments S.A (BVMT:UMED)
Tunisia · Delayed Price · Currency is TND 9.15
+0.05 (0.55%)
At close: Aug 15, 2025
Unité de Fabrication des Médicaments S.A Company Description
Unité de Fabrication des Médicaments S.A. develops, manufactures, markets, and sells generic medicines under the UNIMED brand in Tunisia, Africa, Asia, and Europe.
The company offers Opthalmic, ENT, and inhalation solutions, infusion solutions, injectable fluids and penicillin, and cephalosporin powders, as well as vaigtaine products in approximately 40 presentations for various therapeutic classes.
It manufactures medicines for third party laboratories principals. Unité de Fabrication des Médicaments S.A. was founded in 1989 and is based in Sousse, Tunisia.
Unité de Fabrication des Médicaments S.A
| Country | Tunisia |
| Founded | 1989 |
| Industry | Pharmaceutical Preparations |
| Employees | 572 |
| CEO | Ridha Charfeddine |
Contact Details
Address: Industrial Zone Kalaa Kebira, BP 38 Sousse, 4060 Tunisia | |
| Phone | 216 70 029 501 |
| Website | unimed.com.tn |
Stock Details
| Ticker Symbol | UMED |
| Exchange | Tunis Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TND |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ridha Charfeddine | Chief Executive Officer |
| Lotfi Charfeddine | Chief Financial Officer |